APLI Intrinsic Valuation and Fundamental Analysis - Appili Therapeutics Inc

Watchlist Manager

Watchlist

Price: 0.005 CAD -50% Market Closed

Market Cap: CA$661.9k

	Appili Therapeutics Inc TSX:APLI	CA
	United Airlines Holdings Inc NASDAQ:UAL	US
C	Changhong Meiling Co Ltd SZSE:200521	CN
B	Boe Varitronix Ltd XMUN:VTX	HK
	Softronic AB STO:SOF B	SE
O	Okta Inc SWB:0OK	US

Intrinsic Value

APLI doesn't have a meaningful market cap.

Is APLI undervalued or overvalued?

See the intrinsic value estimate for Appili Therapeutics Inc and find out whether today’s valuation is cheap or expensive by its own historical standards.

Do our valuations actually work? See backtest results .

APLI Intrinsic Value

Unlock

Today vs. history

See how today’s valuation compares with APLI’s past valuations and how the stock performed after similar periods.

See what happened next Free account required

Track Buy Zone

20% below Intrinsic Value

Get notified when the price drops into your buy zone

Intrinsic Value Locked

Current Price CA$0.01

Margin of Safety 20% Locked

Or choose another margin of safety

0% below Intrinsic Value

10% below Intrinsic Value

30% below Intrinsic Value

40% below Intrinsic Value

50% below Intrinsic Value

Custom

Fundamental Analysis

What Appili Therapeutics Does

Pharmaceuticals Health Care

Appili Therapeutics, Inc. operates as a biopharmaceutical company, which acquires and develops novel treatments targeting unmet needs in infectious disease. The company is headquartered in Halifax, Nova Scotia. The company went IPO on 2019-06-25. The firm is advancing a diverse range of anti-infectives, including an FDA-approved ready-made suspension of metronidazole for the treatment of antimicrobial-resistant infections, a vaccine candidate to eliminate a serious biological weapon threat, and a topical antiparasitic for the treatment of a disfiguring disease.

Headquarters: Canada CA
Employees: 7
IPO date: Jun 25, 2019